Evaxion Biotech (EVAX) Misses Q3 EPS by 4c

Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $3.01 million.

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• CLSA Upgrades Baozun (BZUN) to Outperform (2)